Skip to main content
Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency.
Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts.
B-cell development and functions and therapeutic options in adenosine deaminase-deficient patients.
Survey on retransplantation criteria for patients with severe combined immunodeficiency.
Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience.
A systematic analysis of recombination activity and genotype-phenotype correlation in human recombination-activating gene 1 deficiency.
Primary Immune Deficiency Treatment Consortium (PIDTC) report.
Newborn screening for severe combined immunodeficiency and T-cell lymphopenia in California: results of the first 2 years.
Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: need for safer conditioning and reduced late effects.
Intermediate phenotypes in patients with autosomal dominant hyper-IgE syndrome caused by somatic mosaicism.